Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
DNA Methylation | 33 | 2023 | 4373 | 1.920 |
Why?
|
Sequence Analysis, DNA | 9 | 2020 | 4713 | 1.030 |
Why?
|
Oligonucleotide Array Sequence Analysis | 11 | 2014 | 3775 | 1.000 |
Why?
|
Epigenesis, Genetic | 24 | 2023 | 3758 | 0.960 |
Why?
|
Software | 7 | 2019 | 4419 | 0.850 |
Why?
|
Chromatin | 15 | 2024 | 2938 | 0.840 |
Why?
|
High-Throughput Nucleotide Sequencing | 11 | 2021 | 3616 | 0.810 |
Why?
|
Single-Cell Analysis | 11 | 2024 | 2380 | 0.690 |
Why?
|
Epigenomics | 12 | 2022 | 936 | 0.670 |
Why?
|
Placentation | 1 | 2017 | 78 | 0.580 |
Why?
|
Genome | 9 | 2019 | 1739 | 0.560 |
Why?
|
Quality Control | 1 | 2019 | 828 | 0.530 |
Why?
|
CpG Islands | 8 | 2021 | 1221 | 0.520 |
Why?
|
Programming Languages | 1 | 2016 | 128 | 0.510 |
Why?
|
Molecular Sequence Annotation | 1 | 2018 | 524 | 0.510 |
Why?
|
Endonucleases | 5 | 2019 | 370 | 0.500 |
Why?
|
Algorithms | 11 | 2019 | 13981 | 0.450 |
Why?
|
DNA | 7 | 2023 | 7233 | 0.430 |
Why?
|
Cell Lineage | 10 | 2024 | 2533 | 0.400 |
Why?
|
Sulfites | 3 | 2021 | 83 | 0.400 |
Why?
|
Meta-Analysis as Topic | 1 | 2016 | 1376 | 0.370 |
Why?
|
Gene Expression Profiling | 11 | 2024 | 9411 | 0.360 |
Why?
|
Computational Biology | 5 | 2020 | 3505 | 0.340 |
Why?
|
Gene Expression Regulation, Neoplastic | 13 | 2024 | 8515 | 0.330 |
Why?
|
Genetic Heterogeneity | 1 | 2013 | 724 | 0.330 |
Why?
|
Genome, Human | 10 | 2021 | 4417 | 0.320 |
Why?
|
Placenta | 1 | 2017 | 1702 | 0.310 |
Why?
|
Substrate Specificity | 4 | 2019 | 1792 | 0.290 |
Why?
|
Diarrhea | 4 | 2016 | 1319 | 0.270 |
Why?
|
High-Throughput Screening Assays | 2 | 2019 | 944 | 0.270 |
Why?
|
Carcinoma | 1 | 2017 | 2331 | 0.260 |
Why?
|
GATA1 Transcription Factor | 3 | 2022 | 296 | 0.260 |
Why?
|
Models, Statistical | 2 | 2019 | 5075 | 0.250 |
Why?
|
Gene Targeting | 4 | 2021 | 839 | 0.250 |
Why?
|
RNA-Binding Protein EWS | 4 | 2023 | 210 | 0.240 |
Why?
|
DNA, Mitochondrial | 2 | 2020 | 858 | 0.230 |
Why?
|
Bone Neoplasms | 3 | 2022 | 2532 | 0.210 |
Why?
|
Hematopoietic Stem Cells | 6 | 2019 | 3387 | 0.210 |
Why?
|
Chromatin Assembly and Disassembly | 2 | 2019 | 633 | 0.210 |
Why?
|
Heterochromatin | 2 | 2022 | 293 | 0.200 |
Why?
|
Metabolomics | 3 | 2021 | 1628 | 0.200 |
Why?
|
Sarcoma, Clear Cell | 1 | 2022 | 72 | 0.190 |
Why?
|
Embryonic Stem Cells | 4 | 2014 | 1262 | 0.190 |
Why?
|
RNA-Directed DNA Polymerase | 1 | 2022 | 224 | 0.190 |
Why?
|
Genomics | 6 | 2019 | 5794 | 0.190 |
Why?
|
Prostatic Neoplasms | 5 | 2023 | 11345 | 0.180 |
Why?
|
Sequence Analysis, RNA | 5 | 2019 | 2005 | 0.180 |
Why?
|
Diploidy | 1 | 2020 | 132 | 0.180 |
Why?
|
Chromosomes | 2 | 2020 | 575 | 0.180 |
Why?
|
Cell Differentiation | 9 | 2024 | 11481 | 0.180 |
Why?
|
Alleles | 3 | 2024 | 6898 | 0.180 |
Why?
|
Cytosine Deaminase | 1 | 2020 | 65 | 0.180 |
Why?
|
Humans | 80 | 2024 | 760621 | 0.180 |
Why?
|
RNA Editing | 2 | 2019 | 151 | 0.180 |
Why?
|
Liver Diseases | 2 | 2019 | 1302 | 0.170 |
Why?
|
Hematopoiesis | 4 | 2020 | 2050 | 0.170 |
Why?
|
DNA Breaks | 1 | 2019 | 47 | 0.170 |
Why?
|
Deoxyribonucleases | 2 | 2019 | 212 | 0.170 |
Why?
|
Carcinoma, Pancreatic Ductal | 2 | 2022 | 1724 | 0.170 |
Why?
|
Chromatin Immunoprecipitation | 2 | 2022 | 858 | 0.160 |
Why?
|
Interleukins | 1 | 2024 | 785 | 0.160 |
Why?
|
Carcinoma, Hepatocellular | 2 | 2024 | 2299 | 0.160 |
Why?
|
Erythropoiesis | 2 | 2022 | 682 | 0.160 |
Why?
|
Deoxyribonucleases, Type II Site-Specific | 2 | 2021 | 168 | 0.160 |
Why?
|
Gene Regulatory Networks | 2 | 2021 | 1741 | 0.160 |
Why?
|
Proto-Oncogene Protein c-fli-1 | 2 | 2021 | 104 | 0.160 |
Why?
|
Th1 Cells | 1 | 2024 | 1032 | 0.160 |
Why?
|
Bacterial Proteins | 3 | 2019 | 3826 | 0.160 |
Why?
|
RNA | 5 | 2022 | 2722 | 0.160 |
Why?
|
Linkage Disequilibrium | 3 | 2019 | 1996 | 0.160 |
Why?
|
DNA, Circular | 1 | 2018 | 97 | 0.160 |
Why?
|
Genome, Plant | 1 | 2018 | 82 | 0.150 |
Why?
|
Proteome | 1 | 2008 | 1855 | 0.150 |
Why?
|
Oncogene Proteins, Fusion | 4 | 2023 | 1596 | 0.150 |
Why?
|
Chimerism | 1 | 2019 | 155 | 0.150 |
Why?
|
Databases, Nucleic Acid | 1 | 2019 | 204 | 0.150 |
Why?
|
Zea mays | 1 | 2018 | 112 | 0.150 |
Why?
|
HEK293 Cells | 7 | 2020 | 4264 | 0.150 |
Why?
|
Histones | 4 | 2022 | 2583 | 0.150 |
Why?
|
Colonic Neoplasms | 3 | 2017 | 2526 | 0.150 |
Why?
|
Cell Cycle Proteins | 2 | 2021 | 3446 | 0.150 |
Why?
|
Mitosis | 1 | 2022 | 1191 | 0.150 |
Why?
|
Hematopoiesis, Extramedullary | 1 | 2017 | 53 | 0.150 |
Why?
|
Virus Integration | 1 | 2019 | 302 | 0.140 |
Why?
|
Chromosome Mapping | 4 | 2019 | 4625 | 0.140 |
Why?
|
Polymorphism, Single Nucleotide | 8 | 2021 | 15789 | 0.140 |
Why?
|
Otx Transcription Factors | 1 | 2017 | 42 | 0.140 |
Why?
|
Streptococcus pyogenes | 2 | 2019 | 294 | 0.140 |
Why?
|
Euchromatin | 1 | 2016 | 54 | 0.140 |
Why?
|
Cerebellum | 1 | 2024 | 1496 | 0.140 |
Why?
|
Colorectal Neoplasms | 5 | 2022 | 6853 | 0.140 |
Why?
|
Enhancer Elements, Genetic | 5 | 2024 | 1356 | 0.140 |
Why?
|
Mitochondria | 2 | 2020 | 3600 | 0.130 |
Why?
|
Promoter Regions, Genetic | 4 | 2021 | 5785 | 0.130 |
Why?
|
K562 Cells | 1 | 2018 | 640 | 0.130 |
Why?
|
Ribonucleoproteins | 1 | 2019 | 372 | 0.130 |
Why?
|
Osteosarcoma | 1 | 2022 | 897 | 0.130 |
Why?
|
Liver Neoplasms | 2 | 2024 | 4319 | 0.130 |
Why?
|
Lung Neoplasms | 4 | 2024 | 13262 | 0.130 |
Why?
|
Interferon-gamma | 1 | 2024 | 3157 | 0.130 |
Why?
|
Schizosaccharomyces pombe Proteins | 1 | 2016 | 178 | 0.130 |
Why?
|
Databases, Genetic | 2 | 2014 | 1738 | 0.130 |
Why?
|
Azacitidine | 1 | 2017 | 334 | 0.120 |
Why?
|
Twins, Monozygotic | 1 | 2016 | 469 | 0.120 |
Why?
|
Pregnancy Trimester, Second | 1 | 2017 | 732 | 0.120 |
Why?
|
Repetitive Sequences, Nucleic Acid | 1 | 2017 | 783 | 0.120 |
Why?
|
Induced Pluripotent Stem Cells | 3 | 2011 | 1846 | 0.120 |
Why?
|
Schizosaccharomyces | 1 | 2016 | 237 | 0.120 |
Why?
|
Dependovirus | 1 | 2019 | 709 | 0.120 |
Why?
|
Clone Cells | 2 | 2020 | 1660 | 0.120 |
Why?
|
Magnetic Resonance Spectroscopy | 2 | 2021 | 3765 | 0.120 |
Why?
|
Bayes Theorem | 3 | 2013 | 2326 | 0.110 |
Why?
|
Workflow | 1 | 2019 | 852 | 0.110 |
Why?
|
Epithelial Cells | 5 | 2019 | 3663 | 0.110 |
Why?
|
Gene Expression Regulation, Fungal | 1 | 2016 | 499 | 0.110 |
Why?
|
Microfluidics | 1 | 2019 | 652 | 0.110 |
Why?
|
Cell Line, Tumor | 10 | 2023 | 16939 | 0.110 |
Why?
|
Jumonji Domain-Containing Histone Demethylases | 1 | 2015 | 174 | 0.110 |
Why?
|
Polymerase Chain Reaction | 2 | 2021 | 6068 | 0.110 |
Why?
|
Methyltransferases | 1 | 2016 | 374 | 0.110 |
Why?
|
Quantitative Trait Loci | 2 | 2019 | 2101 | 0.110 |
Why?
|
Pregnancy Trimester, First | 1 | 2017 | 908 | 0.110 |
Why?
|
Polymers | 1 | 2020 | 1621 | 0.110 |
Why?
|
Soft Tissue Neoplasms | 1 | 2022 | 1152 | 0.110 |
Why?
|
Pancreatic Neoplasms | 2 | 2022 | 5351 | 0.110 |
Why?
|
Animals | 23 | 2024 | 167963 | 0.110 |
Why?
|
Access to Information | 1 | 2016 | 320 | 0.110 |
Why?
|
Cells | 1 | 2014 | 164 | 0.100 |
Why?
|
Transcription Factors | 4 | 2021 | 12103 | 0.100 |
Why?
|
Anemia | 1 | 2022 | 1511 | 0.100 |
Why?
|
Mice | 14 | 2024 | 81208 | 0.100 |
Why?
|
Zebrafish | 3 | 2021 | 2997 | 0.100 |
Why?
|
Genome-Wide Association Study | 7 | 2019 | 12626 | 0.100 |
Why?
|
NFI Transcription Factors | 1 | 2012 | 42 | 0.100 |
Why?
|
Proto-Oncogene Proteins c-met | 1 | 2016 | 567 | 0.100 |
Why?
|
Cerebellar Neoplasms | 1 | 2017 | 587 | 0.100 |
Why?
|
Haplotypes | 1 | 2018 | 2764 | 0.100 |
Why?
|
Endothelial Cells | 1 | 2024 | 3539 | 0.100 |
Why?
|
Methionine Sulfoxide Reductases | 1 | 2012 | 76 | 0.100 |
Why?
|
Binding Sites | 4 | 2024 | 6048 | 0.100 |
Why?
|
Medulloblastoma | 1 | 2017 | 679 | 0.100 |
Why?
|
Protein Engineering | 1 | 2015 | 541 | 0.100 |
Why?
|
Insect Vectors | 1 | 2012 | 134 | 0.090 |
Why?
|
Graft vs Host Disease | 1 | 2023 | 3025 | 0.090 |
Why?
|
DNA, Intergenic | 1 | 2011 | 105 | 0.090 |
Why?
|
Gene Expression Regulation | 5 | 2024 | 11903 | 0.090 |
Why?
|
Neoplasms | 6 | 2022 | 22072 | 0.090 |
Why?
|
Cell Nucleolus | 1 | 2011 | 156 | 0.090 |
Why?
|
DNA Restriction Enzymes | 1 | 2010 | 553 | 0.090 |
Why?
|
Evolution, Molecular | 1 | 2019 | 1885 | 0.090 |
Why?
|
Malaria Vaccines | 1 | 2012 | 164 | 0.090 |
Why?
|
Tumor Microenvironment | 2 | 2024 | 3844 | 0.090 |
Why?
|
Lysine | 1 | 2015 | 1001 | 0.090 |
Why?
|
Protein Binding | 5 | 2016 | 9335 | 0.090 |
Why?
|
DNA Breaks, Double-Stranded | 1 | 2014 | 607 | 0.090 |
Why?
|
Mice, Inbred NOD | 3 | 2021 | 1837 | 0.090 |
Why?
|
Plasmodium vivax | 1 | 2012 | 202 | 0.090 |
Why?
|
Genetic Vectors | 1 | 2019 | 3380 | 0.090 |
Why?
|
Mutation | 9 | 2020 | 29932 | 0.090 |
Why?
|
Major Histocompatibility Complex | 1 | 2013 | 928 | 0.090 |
Why?
|
Gene Rearrangement | 2 | 2016 | 1122 | 0.080 |
Why?
|
Arthritis, Rheumatoid | 2 | 2016 | 3763 | 0.080 |
Why?
|
Developing Countries | 2 | 2012 | 2868 | 0.080 |
Why?
|
Chromosomes, Human | 1 | 2011 | 442 | 0.080 |
Why?
|
Base Sequence | 5 | 2019 | 12446 | 0.080 |
Why?
|
Cell Line | 6 | 2021 | 15620 | 0.080 |
Why?
|
Protein Structure, Tertiary | 2 | 2013 | 3800 | 0.080 |
Why?
|
Cytosine | 2 | 2020 | 212 | 0.080 |
Why?
|
DNA-Binding Proteins | 4 | 2019 | 9585 | 0.080 |
Why?
|
Reproducibility of Results | 4 | 2021 | 20080 | 0.080 |
Why?
|
Osteoblasts | 3 | 2021 | 1142 | 0.080 |
Why?
|
Guanine Nucleotide Exchange Factors | 1 | 2012 | 568 | 0.080 |
Why?
|
Autoantibodies | 1 | 2016 | 2118 | 0.070 |
Why?
|
Conserved Sequence | 1 | 2011 | 1167 | 0.070 |
Why?
|
Leukemia, Lymphocytic, Chronic, B-Cell | 1 | 2019 | 1628 | 0.070 |
Why?
|
Hematopoietic Stem Cell Transplantation | 2 | 2023 | 5649 | 0.070 |
Why?
|
Keratinocytes | 1 | 2011 | 792 | 0.070 |
Why?
|
RNA, Small Interfering | 1 | 2016 | 3442 | 0.070 |
Why?
|
Two-Hybrid System Techniques | 1 | 2008 | 458 | 0.070 |
Why?
|
Protein Biosynthesis | 1 | 2015 | 2105 | 0.070 |
Why?
|
Early Detection of Cancer | 1 | 2021 | 3202 | 0.070 |
Why?
|
Brain Chemistry | 1 | 2010 | 959 | 0.070 |
Why?
|
CD8-Positive T-Lymphocytes | 2 | 2024 | 4550 | 0.070 |
Why?
|
Brain | 6 | 2019 | 26951 | 0.070 |
Why?
|
Prostate | 2 | 2011 | 1793 | 0.070 |
Why?
|
Mesenchymal Stem Cells | 2 | 2017 | 1634 | 0.060 |
Why?
|
Oncogenes | 3 | 2022 | 1220 | 0.060 |
Why?
|
Proto-Oncogene Proteins c-myc | 1 | 2011 | 995 | 0.060 |
Why?
|
Recombinant Fusion Proteins | 1 | 2014 | 3735 | 0.060 |
Why?
|
DNA, Neoplasm | 1 | 2010 | 1745 | 0.060 |
Why?
|
Fetal Blood | 1 | 2011 | 1343 | 0.060 |
Why?
|
Regulatory Sequences, Nucleic Acid | 2 | 2019 | 788 | 0.060 |
Why?
|
Depressive Disorder, Major | 2 | 2013 | 4744 | 0.060 |
Why?
|
Data Interpretation, Statistical | 1 | 2014 | 2696 | 0.060 |
Why?
|
Behavior, Animal | 1 | 2012 | 1866 | 0.060 |
Why?
|
Lymphocytes | 3 | 2019 | 2611 | 0.060 |
Why?
|
Spleen | 1 | 2010 | 2298 | 0.060 |
Why?
|
Neoplastic Cells, Circulating | 2 | 2023 | 938 | 0.060 |
Why?
|
Gene Silencing | 1 | 2010 | 1513 | 0.060 |
Why?
|
Infant, Newborn | 5 | 2016 | 26181 | 0.060 |
Why?
|
Toxoplasmosis | 1 | 2024 | 93 | 0.060 |
Why?
|
Internet | 1 | 2016 | 3078 | 0.060 |
Why?
|
Female | 20 | 2024 | 391270 | 0.060 |
Why?
|
Aging | 1 | 2022 | 8651 | 0.060 |
Why?
|
Antibodies | 1 | 2012 | 2421 | 0.060 |
Why?
|
Toxoplasma | 1 | 2024 | 151 | 0.050 |
Why?
|
Sensitivity and Specificity | 2 | 2017 | 14660 | 0.050 |
Why?
|
Gestational Age | 1 | 2012 | 3565 | 0.050 |
Why?
|
Male | 19 | 2024 | 359744 | 0.050 |
Why?
|
DNA Primers | 2 | 2021 | 2819 | 0.050 |
Why?
|
Cell Nucleus | 2 | 2022 | 2907 | 0.050 |
Why?
|
Colon | 1 | 2010 | 1788 | 0.050 |
Why?
|
Nerve Tissue Proteins | 2 | 2012 | 4407 | 0.050 |
Why?
|
Infant | 5 | 2016 | 36060 | 0.050 |
Why?
|
Cost of Illness | 1 | 2012 | 1940 | 0.050 |
Why?
|
Neoplasm Metastasis | 1 | 2013 | 4902 | 0.050 |
Why?
|
CD4-Positive T-Lymphocytes | 1 | 2014 | 4353 | 0.050 |
Why?
|
Kidney | 1 | 2017 | 7064 | 0.050 |
Why?
|
Mice, SCID | 2 | 2019 | 2627 | 0.050 |
Why?
|
Life Cycle Stages | 1 | 2022 | 160 | 0.050 |
Why?
|
POU Domain Factors | 1 | 2021 | 47 | 0.050 |
Why?
|
Child, Preschool | 5 | 2016 | 42063 | 0.050 |
Why?
|
Aged | 11 | 2021 | 169152 | 0.050 |
Why?
|
Apolipoproteins A | 1 | 2021 | 95 | 0.050 |
Why?
|
MyoD Protein | 1 | 2021 | 142 | 0.050 |
Why?
|
beta-Globins | 1 | 2021 | 108 | 0.050 |
Why?
|
Lamivudine | 1 | 2022 | 363 | 0.050 |
Why?
|
Mice, Inbred C57BL | 4 | 2024 | 22023 | 0.040 |
Why?
|
Myeloid Cells | 2 | 2019 | 820 | 0.040 |
Why?
|
Electroporation | 1 | 2021 | 255 | 0.040 |
Why?
|
Adaptor Proteins, Signal Transducing | 1 | 2010 | 2895 | 0.040 |
Why?
|
Interleukin-2 Receptor alpha Subunit | 1 | 2021 | 305 | 0.040 |
Why?
|
Petromyzon | 1 | 2019 | 7 | 0.040 |
Why?
|
Incidence | 2 | 2016 | 21392 | 0.040 |
Why?
|
Targeted Gene Repair | 1 | 2019 | 20 | 0.040 |
Why?
|
Apolipoprotein C-III | 1 | 2021 | 209 | 0.040 |
Why?
|
Chemokines | 1 | 2024 | 962 | 0.040 |
Why?
|
Multifactor Dimensionality Reduction | 1 | 2019 | 10 | 0.040 |
Why?
|
Bacteriophage lambda | 1 | 2019 | 142 | 0.040 |
Why?
|
Deamination | 1 | 2019 | 25 | 0.040 |
Why?
|
HCT116 Cells | 1 | 2020 | 402 | 0.040 |
Why?
|
Acidaminococcus | 1 | 2019 | 9 | 0.040 |
Why?
|
Doxycycline | 1 | 2021 | 341 | 0.040 |
Why?
|
Fibroblasts | 1 | 2009 | 4090 | 0.040 |
Why?
|
Combinatorial Chemistry Techniques | 1 | 2019 | 132 | 0.040 |
Why?
|
Transposases | 1 | 2019 | 103 | 0.040 |
Why?
|
Genetic Predisposition to Disease | 3 | 2018 | 17790 | 0.040 |
Why?
|
Genetic Markers | 2 | 2016 | 2608 | 0.040 |
Why?
|
Erythroid Precursor Cells | 1 | 2019 | 211 | 0.040 |
Why?
|
Microscopy, Electron, Transmission | 1 | 2020 | 697 | 0.040 |
Why?
|
Steroids | 1 | 2023 | 928 | 0.040 |
Why?
|
Interferons | 1 | 2022 | 705 | 0.040 |
Why?
|
Neurons | 2 | 2019 | 9426 | 0.040 |
Why?
|
Cell Survival | 2 | 2019 | 5797 | 0.040 |
Why?
|
Hep G2 Cells | 1 | 2019 | 389 | 0.040 |
Why?
|
Prognosis | 3 | 2024 | 29658 | 0.040 |
Why?
|
Myoblasts | 1 | 2019 | 232 | 0.040 |
Why?
|
Interferon Regulatory Factors | 1 | 2019 | 260 | 0.040 |
Why?
|
Myeloid Progenitor Cells | 1 | 2018 | 114 | 0.040 |
Why?
|
Immunity, Cellular | 1 | 2023 | 1557 | 0.040 |
Why?
|
Neoplasm Recurrence, Local | 1 | 2016 | 9276 | 0.040 |
Why?
|
Valine | 1 | 2019 | 409 | 0.040 |
Why?
|
Th17 Cells | 1 | 2024 | 787 | 0.040 |
Why?
|
Erythroid Cells | 1 | 2019 | 235 | 0.040 |
Why?
|
INDEL Mutation | 1 | 2018 | 266 | 0.040 |
Why?
|
Molecular Dynamics Simulation | 1 | 2020 | 435 | 0.040 |
Why?
|
Carcinoma, Non-Small-Cell Lung | 1 | 2016 | 5251 | 0.040 |
Why?
|
Cell Communication | 1 | 2024 | 1653 | 0.040 |
Why?
|
Metabolic Networks and Pathways | 1 | 2021 | 789 | 0.040 |
Why?
|
Biological Clocks | 1 | 2019 | 316 | 0.030 |
Why?
|
Middle Aged | 11 | 2021 | 220352 | 0.030 |
Why?
|
Hippocampus | 2 | 2024 | 3738 | 0.030 |
Why?
|
Base Pair Mismatch | 1 | 2016 | 92 | 0.030 |
Why?
|
Plasmids | 1 | 2021 | 2275 | 0.030 |
Why?
|
Kruppel-Like Transcription Factors | 1 | 2019 | 503 | 0.030 |
Why?
|
Glutamine | 1 | 2019 | 576 | 0.030 |
Why?
|
Cluster Analysis | 2 | 2014 | 2698 | 0.030 |
Why?
|
Aged, 80 and over | 6 | 2020 | 58995 | 0.030 |
Why?
|
Glycine | 1 | 2019 | 662 | 0.030 |
Why?
|
Flow Cytometry | 2 | 2019 | 5870 | 0.030 |
Why?
|
Chromosomal Proteins, Non-Histone | 1 | 2021 | 727 | 0.030 |
Why?
|
Gene Library | 1 | 2018 | 1060 | 0.030 |
Why?
|
Pregnancy | 1 | 2017 | 29749 | 0.030 |
Why?
|
Streptococcus thermophilus | 1 | 2015 | 22 | 0.030 |
Why?
|
RNA Interference | 2 | 2016 | 2846 | 0.030 |
Why?
|
Coculture Techniques | 1 | 2019 | 1342 | 0.030 |
Why?
|
Transcriptional Activation | 1 | 2021 | 1755 | 0.030 |
Why?
|
Peptide Initiation Factors | 1 | 2015 | 55 | 0.030 |
Why?
|
Transgenes | 1 | 2018 | 1006 | 0.030 |
Why?
|
Principal Component Analysis | 1 | 2018 | 940 | 0.030 |
Why?
|
STAT3 Transcription Factor | 1 | 2019 | 877 | 0.030 |
Why?
|
Liver | 1 | 2010 | 7509 | 0.030 |
Why?
|
Gene Expression Regulation, Enzymologic | 1 | 2019 | 1173 | 0.030 |
Why?
|
Apoptosis | 1 | 2010 | 9501 | 0.030 |
Why?
|
Muscles | 1 | 2019 | 1581 | 0.030 |
Why?
|
Adenine | 1 | 2020 | 975 | 0.030 |
Why?
|
Hydrazones | 1 | 2015 | 102 | 0.030 |
Why?
|
Peptide Chain Initiation, Translational | 1 | 2015 | 100 | 0.030 |
Why?
|
In Situ Hybridization, Fluorescence | 1 | 2020 | 2506 | 0.030 |
Why?
|
Directed Molecular Evolution | 1 | 2015 | 158 | 0.030 |
Why?
|
Mitogen-Activated Protein Kinases | 1 | 2019 | 1246 | 0.030 |
Why?
|
Mutagenesis | 1 | 2018 | 1234 | 0.030 |
Why?
|
Epithelial-Mesenchymal Transition | 1 | 2019 | 730 | 0.030 |
Why?
|
Cells, Cultured | 2 | 2020 | 18957 | 0.030 |
Why?
|
Transcription, Genetic | 2 | 2019 | 7593 | 0.030 |
Why?
|
Sequence Alignment | 1 | 2018 | 2176 | 0.030 |
Why?
|
Chromosomes, Human, Pair 14 | 1 | 2014 | 286 | 0.030 |
Why?
|
Cloning, Molecular | 1 | 2019 | 4169 | 0.030 |
Why?
|
Caliciviridae Infections | 1 | 2013 | 29 | 0.030 |
Why?
|
Stromal Cells | 1 | 2019 | 1326 | 0.030 |
Why?
|
Models, Genetic | 2 | 2014 | 3442 | 0.030 |
Why?
|
RNA, Small Untranslated | 1 | 2014 | 77 | 0.030 |
Why?
|
Cochlea | 1 | 2019 | 844 | 0.030 |
Why?
|
Acute Disease | 1 | 2023 | 7269 | 0.030 |
Why?
|
Xenograft Model Antitumor Assays | 1 | 2021 | 3584 | 0.030 |
Why?
|
Cell Division | 1 | 2020 | 4463 | 0.030 |
Why?
|
Neoplasm Staging | 2 | 2019 | 11152 | 0.030 |
Why?
|
RNA, Messenger | 2 | 2021 | 12766 | 0.030 |
Why?
|
Oligodeoxyribonucleotides | 1 | 2014 | 778 | 0.030 |
Why?
|
Bees | 1 | 2012 | 45 | 0.030 |
Why?
|
T-Lymphocytes | 2 | 2021 | 10181 | 0.030 |
Why?
|
Body Mass Index | 1 | 2010 | 12914 | 0.030 |
Why?
|
Rotavirus Infections | 1 | 2013 | 85 | 0.030 |
Why?
|
Intestinal Mucosa | 1 | 2023 | 3022 | 0.030 |
Why?
|
Ribosomal Proteins | 1 | 2015 | 363 | 0.030 |
Why?
|
Animals, Genetically Modified | 1 | 2017 | 1553 | 0.030 |
Why?
|
Histone-Lysine N-Methyltransferase | 1 | 2016 | 678 | 0.030 |
Why?
|
Leukocytes, Mononuclear | 1 | 2019 | 1827 | 0.030 |
Why?
|
Methylation | 1 | 2015 | 1082 | 0.020 |
Why?
|
Homeodomain Proteins | 1 | 2021 | 2414 | 0.020 |
Why?
|
Signal Transduction | 3 | 2024 | 23376 | 0.020 |
Why?
|
Tumor Suppressor Protein p53 | 1 | 2022 | 2919 | 0.020 |
Why?
|
Protein Conformation | 1 | 2019 | 3969 | 0.020 |
Why?
|
Insect Proteins | 1 | 2012 | 254 | 0.020 |
Why?
|
Transfection | 1 | 2019 | 5781 | 0.020 |
Why?
|
Neoadjuvant Therapy | 1 | 2022 | 2821 | 0.020 |
Why?
|
Intracellular Signaling Peptides and Proteins | 1 | 2021 | 2873 | 0.020 |
Why?
|
Genes, Regulator | 1 | 2012 | 374 | 0.020 |
Why?
|
Aminopyridines | 1 | 2015 | 564 | 0.020 |
Why?
|
Plasmodium berghei | 1 | 2012 | 159 | 0.020 |
Why?
|
Oligonucleotide Probes | 1 | 2011 | 418 | 0.020 |
Why?
|
Vocabulary, Controlled | 1 | 2012 | 167 | 0.020 |
Why?
|
Basic Helix-Loop-Helix Transcription Factors | 1 | 2017 | 1139 | 0.020 |
Why?
|
Neoplasm Transplantation | 1 | 2014 | 2014 | 0.020 |
Why?
|
Amino Acid Substitution | 1 | 2015 | 1737 | 0.020 |
Why?
|
Nuclear Transfer Techniques | 1 | 2010 | 61 | 0.020 |
Why?
|
Likelihood Functions | 1 | 2013 | 987 | 0.020 |
Why?
|
Chemical Fractionation | 1 | 2010 | 62 | 0.020 |
Why?
|
Enzyme Activation | 1 | 2016 | 3602 | 0.020 |
Why?
|
Tumor Suppressor Proteins | 1 | 2020 | 2802 | 0.020 |
Why?
|
Genes, Neoplasm | 1 | 2012 | 370 | 0.020 |
Why?
|
Markov Chains | 1 | 2013 | 968 | 0.020 |
Why?
|
Exons | 1 | 2016 | 2388 | 0.020 |
Why?
|
Mice, Inbred CBA | 1 | 2010 | 436 | 0.020 |
Why?
|
Genes, myc | 1 | 2011 | 395 | 0.020 |
Why?
|
DNA Topoisomerases, Type II | 1 | 2010 | 124 | 0.020 |
Why?
|
Anopheles | 1 | 2012 | 192 | 0.020 |
Why?
|
Nucleic Acid Hybridization | 1 | 2011 | 1304 | 0.020 |
Why?
|
Antiviral Agents | 1 | 2022 | 3061 | 0.020 |
Why?
|
Rats | 2 | 2019 | 23711 | 0.020 |
Why?
|
Amino Acid Sequence | 1 | 2021 | 13451 | 0.020 |
Why?
|
Escherichia coli Infections | 1 | 2013 | 523 | 0.020 |
Why?
|
Vaccines, Synthetic | 1 | 2012 | 617 | 0.020 |
Why?
|
Cytokines | 1 | 2024 | 7343 | 0.020 |
Why?
|
Cell Movement | 1 | 2021 | 5206 | 0.020 |
Why?
|
Membrane Proteins | 2 | 2019 | 7850 | 0.020 |
Why?
|
Gene Knockdown Techniques | 1 | 2013 | 1617 | 0.020 |
Why?
|
Protein Multimerization | 1 | 2014 | 983 | 0.020 |
Why?
|
Sex Factors | 2 | 2013 | 10547 | 0.020 |
Why?
|
Microarray Analysis | 1 | 2011 | 747 | 0.020 |
Why?
|
Drug Resistance | 1 | 2015 | 1617 | 0.020 |
Why?
|
Immunotherapy | 1 | 2024 | 4642 | 0.020 |
Why?
|
Magnetics | 1 | 2011 | 600 | 0.020 |
Why?
|
Phenotype | 2 | 2019 | 16546 | 0.020 |
Why?
|
Smoking | 2 | 2016 | 9073 | 0.020 |
Why?
|
Gene Expression Regulation, Developmental | 1 | 2019 | 3604 | 0.020 |
Why?
|
Microscopy, Electron | 1 | 2011 | 2558 | 0.020 |
Why?
|
Nucleic Acid Amplification Techniques | 1 | 2010 | 330 | 0.020 |
Why?
|
Mice, Transgenic | 1 | 2019 | 9530 | 0.020 |
Why?
|
Staphylococcus aureus | 1 | 2015 | 1462 | 0.020 |
Why?
|
Uncertainty | 1 | 2012 | 754 | 0.020 |
Why?
|
Survival Analysis | 1 | 2019 | 10182 | 0.020 |
Why?
|
Nuclear Proteins | 1 | 2021 | 5791 | 0.020 |
Why?
|
Hypothalamus | 1 | 2011 | 998 | 0.020 |
Why?
|
Quality-Adjusted Life Years | 1 | 2012 | 1724 | 0.020 |
Why?
|
Age Factors | 2 | 2013 | 18416 | 0.020 |
Why?
|
TOR Serine-Threonine Kinases | 1 | 2015 | 2058 | 0.020 |
Why?
|
Predictive Value of Tests | 1 | 2021 | 15289 | 0.020 |
Why?
|
Serine Endopeptidases | 1 | 2010 | 1021 | 0.020 |
Why?
|
Case-Control Studies | 2 | 2013 | 22053 | 0.020 |
Why?
|
Molecular Targeted Therapy | 1 | 2016 | 2803 | 0.010 |
Why?
|
Child | 3 | 2023 | 79806 | 0.010 |
Why?
|
Macrophages | 1 | 2019 | 5745 | 0.010 |
Why?
|
Adolescent | 4 | 2013 | 87810 | 0.010 |
Why?
|
Receptors, Androgen | 1 | 2010 | 1077 | 0.010 |
Why?
|
Cohort Studies | 2 | 2020 | 41335 | 0.010 |
Why?
|
Genotype | 1 | 2018 | 12960 | 0.010 |
Why?
|
Linear Models | 1 | 2014 | 5877 | 0.010 |
Why?
|
Pluripotent Stem Cells | 1 | 2010 | 792 | 0.010 |
Why?
|
Metabolome | 1 | 2010 | 982 | 0.010 |
Why?
|
Chronic Disease | 1 | 2018 | 9287 | 0.010 |
Why?
|
Cell Proliferation | 1 | 2019 | 10446 | 0.010 |
Why?
|
Breast Neoplasms | 1 | 2010 | 21025 | 0.010 |
Why?
|
Mice, Inbred BALB C | 1 | 2012 | 6216 | 0.010 |
Why?
|
Anti-Bacterial Agents | 1 | 2021 | 7408 | 0.010 |
Why?
|
Androgens | 1 | 2010 | 1291 | 0.010 |
Why?
|
Genetic Association Studies | 1 | 2012 | 2717 | 0.010 |
Why?
|
Adult | 5 | 2018 | 219994 | 0.010 |
Why?
|
Regression Analysis | 1 | 2012 | 6360 | 0.010 |
Why?
|
Malaria | 1 | 2012 | 1226 | 0.010 |
Why?
|
Mortality | 1 | 2012 | 2916 | 0.010 |
Why?
|
Repressor Proteins | 1 | 2012 | 2981 | 0.010 |
Why?
|
Cell Transformation, Neoplastic | 1 | 2010 | 2828 | 0.010 |
Why?
|
Rats, Sprague-Dawley | 1 | 2011 | 8158 | 0.010 |
Why?
|
Protein Kinase Inhibitors | 1 | 2015 | 5643 | 0.010 |
Why?
|
Young Adult | 2 | 2012 | 58741 | 0.010 |
Why?
|
Risk Factors | 2 | 2013 | 74359 | 0.010 |
Why?
|
Disease Progression | 1 | 2010 | 13502 | 0.010 |
Why?
|
Adenocarcinoma | 1 | 2011 | 6315 | 0.010 |
Why?
|
Treatment Outcome | 1 | 2019 | 65017 | 0.010 |
Why?
|
Risk Assessment | 1 | 2012 | 24123 | 0.010 |
Why?
|
Time Factors | 1 | 2010 | 40165 | 0.000 |
Why?
|
Antineoplastic Agents | 1 | 2010 | 13630 | 0.000 |
Why?
|